Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03149523
What this trial is testing

Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors

Who this might be right for
Colorectal AdenocarcinomaHepatic CarcinomaKidney Adenocarcinoma
European Georges Pompidou Hospital 150
Testing effectiveness (Phase 2)Study completedNCT00560560
What this trial is testing

Study Using CP-751,871 In Patients With Stage IV Colorectal Cancer That Has Not Responded To Previous Anti-Cancer Treatments

Who this might be right for
Colorectal Neoplasm
Pfizer 168
Not applicableEnded earlyNCT05526079
What this trial is testing

Watchful Waiting for Complete Responders to Therapy in Rectal Cancer

Who this might be right for
Rectal Cancer
Henry Ford Health System 15
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT04008797
What this trial is testing

E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

Who this might be right for
Endometrial NeoplasmsNeoplasmsCarcinoma, Hepatocellular+2 more
Eisai Inc. 301
Early research (Phase 1)Study completedNCT04440943
What this trial is testing

The PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerBreast CancerGastric Cancer+11 more
Celldex Therapeutics 27
Not applicableEnded earlyNCT01163526
What this trial is testing

Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies

Who this might be right for
Neuroendocrine TumorsBrain (Nervous System) CancersColon/Rectal Cancer+4 more
Stanford University 13
Early research (Phase 1)Study completedNCT03415126
What this trial is testing

ASN007 in Patients With Advanced Solid Tumors

Who this might be right for
CancerMalignancyNeoplasia+16 more
Asana BioSciences 49
Testing effectiveness (Phase 2)Study completedNCT00103142
What this trial is testing

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Michael Morse, MD 74
Testing effectiveness (Phase 2)WithdrawnNCT00003486
What this trial is testing

Antineoplaston Therapy in Treating Patients With Colon Cancer

Who this might be right for
Stage IV Colon CancerRecurrent Colon CancerAdenocarcinoma of the Colon
Burzynski Research Institute
Testing effectiveness (Phase 2)Study completedNCT00686166
What this trial is testing

S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer

Who this might be right for
Colorectal Cancer
SWOG Cancer Research Network 83
Testing effectiveness (Phase 2)Active Not RecruitingNCT05651022
What this trial is testing

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultHCC - Hepatocellular CarcinomaCRC (Colorectal Cancer)+5 more
Indaptus Therapeutics, Inc 120
Not applicableUnknownNCT04430127
What this trial is testing

The Role of Quantitative Measures on Dual-energy CT in the Prediction of Colorectal Adenocarcinoma

Who this might be right for
Colorectal Adenocarcinoma
Hôpital Fribourgeois 50
Testing effectiveness (Phase 2)Study completedNCT00055822
What this trial is testing

Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
The University of Texas Health Science Center at San Antonio 16
Not applicableUnknownNCT00797251
What this trial is testing

Anatomical Right Posterior Sectionectomy of the Liver by IOUS-Guided Finger Compression

Who this might be right for
Colorectal Liver MetastasesHepatocellular CarcinomaLiver Malignancies
University of Milan 10
Testing effectiveness (Phase 2)Study completedNCT00003441
What this trial is testing

Irofulven in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
M.D. Anderson Cancer Center 26
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT00911170
What this trial is testing

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Who this might be right for
CancerColon CancerColorectal Cancer+5 more
Amgen 847
Early research (Phase 1)Study completedNCT04088786
What this trial is testing

Phase I Trial HIPEC With Nal-irinotecan

Who this might be right for
Peritoneal CancerPseudomyxoma PeritoneiMucinous Adenocarcinoma+5 more
Stony Brook University 18
Early research (Phase 1)Active Not RecruitingNCT02298959
What this trial is testing

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Colorectal CarcinomaMetastatic Malignant Solid Neoplasm+12 more
National Cancer Institute (NCI) 59
Next Page